Attention IASLC Voting Members!!

Check your email for "Your Vote Matters: Cast Your Ballot on IASLC Bylaws Today" OR cast your ballot here: https://app.propfuel.com/checkin/embed/0134a829-044f-4013-9a86-9673a398e121

Metastatic NSCLC with ROS1 Rearrangement and Multiple Acquired Resistance Mechanisms to Tyrosine Kinase Inhibitor Therapy: Chasing the Target

shaverdashvili full page

Download (1.32 MB)

General

Metastatic NSCLC with ROS1 Rearrangement and Multiple Acquired Resistance Mechanisms to Tyrosine Kinase Inhibitor Therapy: Chasing the Target

Khvaramze Shaverdashvili, MD
Timothy F. Burns, MD, PhD
United States